Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | 0.890 | 0.154 | 1.3E-21 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
LHFPL tetraspan subfamily member 5 | 0.861 | 0.192 | 4.0E-04 |
|
disease | 0.340 | definitive | 1.000 | 10 | 0 | 2005 | 2018 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
phenotype | 0.300 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
phenotype | 0.300 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
disease | 0.300 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
disease | 0.510 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
phenotype | 0.300 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
disease | 0.300 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
disease | 0.300 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
stereocilin | 0.700 | 0.192 | 1.8E-15 |
|
disease | 0.320 | definitive | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
leucine rich transmembrane and O-methyltransferase domain containing | 0.792 | 0.192 | 7.0E-05 |
|
disease | 0.900 | definitive | 1.000 | 4 | 0 | 2008 | 2017 | ||||||||
|
CEA cell adhesion molecule 16, tectorial membrane component | 0.805 | 0.192 | 1.6E-05 |
|
disease | 0.320 | moderate | 1.000 | 4 | 0 | 2011 | 2015 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.310 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
pentatricopeptide repeat domain 3 | 0.769 | 0.192 | 2.5E-22 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
RAS guanyl releasing protein 2 | 0.769 | 0.231 | 0.24 |
|
disease | 0.700 | definitive | 1.000 | 9 | 0 | 1998 | 2018 | ||||||||
|
RAN guanine nucleotide release factor | 0.751 | 0.231 | 2.4E-05 |
|
disease | 0.550 | disputed | 0.889 | 6 | 0 | 2008 | 2019 | ||||||||
|
otogelin | 0.805 | 0.231 | 6.6E-37 |
|
disease | 0.300 | definitive | 1.000 | 6 | 0 | 1997 | 2017 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 4 | 0.653 | 0.231 | 3.1E-02 |
|
disease | 0.320 | disputed | 1.000 | 6 | 0 | 1997 | 2017 | ||||||||
|
RAD50 interactor 1 | 0.743 | 0.231 | 5.3E-13 |
|
disease | 0.300 | disputed | 1.000 | 5 | 0 | 2001 | 2016 | ||||||||
|
lipoxygenase homology domains 1 | 0.792 | 0.231 | 5.6E-26 |
|
disease | 0.310 | definitive | 1.000 | 3 | 0 | 2009 | 2016 |